| Neoadjuvant nivolumab plus chemotherapy in resectable lung cancer PM Forde, J Spicer, S Lu, M Provencio, T Mitsudomi, MM Awad, E Felip, ... New England Journal of Medicine 386 (21), 1973-1985, 2022 | 1888 | 2022 |
| Organoid profiling identifies common responders to chemotherapy in pancreatic cancer H Tiriac, P Belleau, DD Engle, D Plenker, A Deschênes, TDD Somerville, ... Cancer discovery 8 (9), 1112-1129, 2018 | 951 | 2018 |
| Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma ED Thompson, M Zahurak, A Murphy, T Cornish, N Cuka, E Abdelfatah, ... Gut 66 (5), 794-801, 2017 | 469 | 2017 |
| Pathologic features of response to neoadjuvant anti-PD-1 in resected non-small-cell lung carcinoma: a proposal for quantitative immune-related pathologic response criteria (irPRC) TR Cottrell, ED Thompson, PM Forde, JE Stein, AS Duffield, ... Annals of Oncology 29 (8), 1853-1860, 2018 | 462 | 2018 |
| PD-L1 (B7-H1) expression and the immune tumor microenvironment in primary and metastatic breast carcinomas A Cimino-Mathews, E Thompson, JM Taube, X Ye, Y Lu, A Meeker, H Xu, ... Human pathology 47 (1), 52-63, 2016 | 376 | 2016 |
| Tumor masses support naive T cell infiltration, activation, and differentiation into effectors ED Thompson, HL Enriquez, YX Fu, VH Engelhard Journal of Experimental Medicine 207 (8), 1791-1804, 2010 | 302 | 2010 |
| Safety and clinical activity of the programmed Death-Ligand 1 inhibitor Durvalumab in combination with poly (ADP-ribose) polymerase inhibitor olaparib or vascular endothelial … JM Lee, A Cimino-Mathews, CJ Peer, A Zimmer, S Lipkowitz, ... Journal of Clinical Oncology 35 (19), 2193-2202, 2017 | 256 | 2017 |
| Effector lymphocyte-induced lymph node-like vasculature enables naive T-cell entry into tumours and enhanced anti-tumour immunity JD Peske, ED Thompson, L Gemta, RA Baylis, YX Fu, VH Engelhard Nature communications 6 (1), 7114, 2015 | 193 | 2015 |
| A multimodality test to guide the management of patients with a pancreatic cyst S Springer, DL Masica, M Dal Molin, C Douville, CJ Thoburn, B Afsari, L Li, ... Science translational medicine 11 (501), eaav4772, 2019 | 163 | 2019 |
| The immune microenvironment of breast ductal carcinoma in situ E Thompson, JM Taube, H Elwood, R Sharma, A Meeker, HN Warzecha, ... Modern Pathology 29 (3), 249-258, 2016 | 163 | 2016 |
| Pan-tumor pathologic scoring of response to PD-(L) 1 blockade JE Stein, EJ Lipson, TR Cottrell, PM Forde, RA Anders, ... Clinical Cancer Research 26 (3), 545-551, 2020 | 137 | 2020 |
| Perioperative Nivolumab in Resectable Lung Cancer CMT Investigators N Engl J Med 16 (390), 1756-1769, 2024 | 126* | 2024 |
| Genomic characterization of malignant progression in neoplastic pancreatic cysts M Noë, N Niknafs, CG Fischer, WM Hackeng, V Beleva Guthrie, ... Nature communications 11 (1), 4085, 2020 | 123 | 2020 |
| Prospective, multi-institutional, real-time next-generation sequencing of pancreatic cyst fluid reveals diverse genomic alterations that improve the clinical management of … A Paniccia, PM Polanco, BA Boone, AI Wald, K McGrath, RE Brand, ... Gastroenterology 164 (1), 117-133. e7, 2023 | 114 | 2023 |
| A phase II study of allogeneic GM-CSF–transfected pancreatic tumor vaccine (GVAX) with ipilimumab as maintenance treatment for metastatic pancreatic cancer AA Wu, KM Bever, WJ Ho, EJ Fertig, N Niu, L Zheng, RM Parkinson, ... Clinical cancer research 26 (19), 5129-5139, 2020 | 112 | 2020 |
| Intraductal papillary mucinous neoplasms arise from multiple independent clones, each with distinct mutations CG Fischer, VB Guthrie, AM Braxton, L Zheng, P Wang, Q Song, JF Griffin, ... Gastroenterology 157 (4), 1123-1137. e22, 2019 | 112 | 2019 |
| CODA: quantitative 3D reconstruction of large tissues at cellular resolution AL Kiemen, AM Braxton, MP Grahn, KS Han, JM Babu, R Reichel, ... Nature Methods 19 (11), 1490-1499, 2022 | 108 | 2022 |
| Why is pancreatic cancer so deadly? The pathologist's view RH Hruban, MM Gaida, E Thompson, SM Hong, M Noë, LAA Brosens, ... The Journal of pathology 248 (2), 131-141, 2019 | 107 | 2019 |
| Multi-omic analyses of changes in the tumor microenvironment of pancreatic adenocarcinoma following neoadjuvant treatment with anti-PD-1 therapy K Li, JA Tandurella, J Gai, Q Zhu, SJ Lim, DL Thomas, T Xia, G Mo, ... Cancer Cell 40 (11), 1374-1391. e7, 2022 | 93 | 2022 |
| Large cell neuroendocrine carcinoma of the head and neck: a clinicopathologic series of 10 cases with an emphasis on HPV status ED Thompson, EB Stelow, SE Mills, WH Westra, JA Bishop The American journal of surgical pathology 40 (4), 471-478, 2016 | 87 | 2016 |
